North America Aquaculture Vaccines Market size surpassed USD 23.3 million in 2020 and is projected to witness over 7.3% CAGR from 2021 to 2027.
Increasing adoption of vaccines by aquaculture farmers for increasing their income is one of the important factors that will propel the market growth. Aquaculture vaccines are type of vaccines that are used to treat diseases of fishes. There are restriction and regulation on use of antibodies for aquaculture in various countries that will drive the market revenue. Also, increase in aquaculture farming in various countries in the region will fuel the market expansion. Factors such as increasing prevalence of the bacterial infection like streptococcosis, vibriosis and pseudomonas, and others are further impelling the aquaculture industry demand.
North America Aquaculture Vaccines Market, 2021 & 2027 (USD Mn)
Get more details on this report - Request Free Sample PDF
Development of advanced and novel vaccines for treatment of various viral and bacterial infections during fish farming will boost the North America aquaculture vaccines market growth. For instance, Hipra launched Icthiovac VR/PD injectable vaccines for treatment of pasteurellosis and vibriosis in seabass. Such strategies by major market players for development and launch of innovative vaccines will drive the market demand. However, complex procedures involved in vaccine development and stringent regulatory policies for vaccine approval will restrain the market growth.
Inactivated aquaculture vaccines market revenue was over USD 18.9 million in 2020. This vaccine is also called as killed vaccines that uses the method of killing pathogen that are cultured ad then developed into vaccines. Inactivated vaccines are used to produce strong immune responses. Induction of strong and long-lasting response will propel the segment growth.
Immersion vaccines segment will show significant growth of 7.8% during the forecast timeframe. Immersion vaccines are used for various purposes in aquaculture farming to protect fish against bacterial and infectious diseases. Growing incidence of bacterial and viral diseases along with clinical trials and R&D activities for development of advanced and novel vaccines will drive the segment growth. Ease of administration and various other advantages associated with immersion vaccines will further boost the segment demand.
The salmon segment accounted for North America aquaculture vaccines market share of 64.2% in 2020. Growing demand for salmon products with increasing demand for protection against bacterial and viral infection will fuel the segment growth. Also, ban on sales of antibiotics for aquaculture will augment the growth of the market for salmons.
Viral infection segment is set to expand at a CAGR of 7.5% to reach USD 6.1 million by 2027. Viruses in aquaculture include infectious haematopoietic necrosis viruses, infectious haemorrhagic septicaemia virus, piscine orthoreovirus, Shrimp hemocyte iridescent virus, Covert mortality nodavirus and Abalone herpesvirus. These viruses are responsible for infectious pancreatic necrosis and salmon anemia. These disorders lead to heavy economic loss in the aquaculture farming. Growing demand to minimize the economic losses and to yield a healthy fish stock will significantly boost the segment growth.
Canada aquaculture vaccines market size is predicted to register growth of 7.1% to cross a valuation of USD 25.1 million by 2027. Major players are focusing on developing novel vaccines that will render strong positive effect on country’s aquaculture industry. Growing burden of diseases such as hepatopancreatic microsporidiosis, acute hepatopancreatic necrosis diseases and others will increase the demand for better management of infectious diseases in fish livestock. Growing demand for vaccination products with increasing demand for protection against bacterial and viral infections will boost the market demand in the country.
Major players in North America aquaculture vaccines market are Zoetis Inc., HIPRA, Merck & Co., Inc., Tecnovax, Veterquimica S.A., and Virbac among others. among others.
Companies undertake various strategies such as mergers, collaborations, new product launch, acquisitions, geographic expansions to strengthen their market share. For instance, in 2017, PharmaQ, a vaccine manufacturing company acquired Nordland Sett Vaks. This acquisition has helped the company to expand its product portfolio.